17 septembre 2024
HIV Community-Based Organizations are Fighting Patent Monopolies on Lenacapavir
Source : ITPC Global Despite the world’s efforts, there have been over a million new cases of HIV each year. Lenacapavir (LEN), a long-acting antiretroviral, could change the trajectory of the global HIV
